Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
19,544,573
-
Share change
-
+1,062,158
-
Total reported value
-
$534,261,000
-
Price per share
-
$27.39
-
Number of holders
-
53
-
Value change
-
+$28,659,314
-
Number of buys
-
31
-
Number of sells
-
24
Institutional Holders of PRINCIPIA BIOPHARMA INC - COM (PRNB) as of Q4 2018
As of 31 Dec 2018,
PRINCIPIA BIOPHARMA INC - COM (PRNB) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,544,573 shares.
The largest 10 holders included
New Leaf Venture Partners, L.L.C., ORBIMED ADVISORS LLC, Morgenthaler Management Partners IX, LLC, Sofinnova Investments, Inc., BAKER BROS. ADVISORS LP, Cormorant Asset Management, LP, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, ADAGE CAPITAL PARTNERS GP, L.L.C., and RTW INVESTMENTS, LP.
This page lists
53
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.